- Home
- FLUX vs OVID Comparison
FLUX vs OVID Comparison
Compare FLUX & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLUX
- OVID
- Stock Information
- Founded
- FLUX N/A
- OVID 2014
- Country
- FLUX United States
- OVID United States
- Employees
- FLUX N/A
- OVID N/A
- Industry
- FLUX Industrial Machinery/Components
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- FLUX Miscellaneous
- OVID Health Care
- Exchange
- FLUX Nasdaq
- OVID Nasdaq
- Market Cap
- FLUX 98.5M
- OVID 117.3M
- IPO Year
- FLUX N/A
- OVID 2017
- Fundamental
- Price
- FLUX $2.37
- OVID $1.39
- Analyst Decision
- FLUX Strong Buy
- OVID Strong Buy
- Analyst Count
- FLUX 2
- OVID 4
- Target Price
- FLUX $6.00
- OVID $3.13
- AVG Volume (30 Days)
- FLUX 989.0K
- OVID 2.3M
- Earning Date
- FLUX 09-16-2025
- OVID 11-13-2025
- Dividend Yield
- FLUX N/A
- OVID N/A
- EPS Growth
- FLUX N/A
- OVID N/A
- EPS
- FLUX N/A
- OVID N/A
- Revenue
- FLUX $66,434,000.00
- OVID $6,651,000.00
- Revenue This Year
- FLUX $8.23
- OVID $1,086.57
- Revenue Next Year
- FLUX $24.72
- OVID N/A
- P/E Ratio
- FLUX N/A
- OVID N/A
- Revenue Growth
- FLUX 9.22
- OVID 1070.95
- 52 Week Low
- FLUX $1.15
- OVID $0.24
- 52 Week High
- FLUX $7.55
- OVID $2.01
- Technical
- Relative Strength Index (RSI)
- FLUX 33.10
- OVID 44.80
- Support Level
- FLUX $5.06
- OVID $1.50
- Resistance Level
- FLUX $7.55
- OVID $1.73
- Average True Range (ATR)
- FLUX 0.93
- OVID 0.13
- MACD
- FLUX -0.49
- OVID -0.05
- Stochastic Oscillator
- FLUX 2.45
- OVID 11.24
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.